These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 29248459)

  • 1. Discrete Pools of Oligomeric Amyloid-β Track with Spatial Learning Deficits in a Mouse Model of Alzheimer Amyloidosis.
    Chiang ACA; Fowler SW; Reddy R; Pletnikova O; Troncoso JC; Sherman MA; Lesne SE; Jankowsky JL
    Am J Pathol; 2018 Mar; 188(3):739-756. PubMed ID: 29248459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible pathologic and cognitive phenotypes in an inducible model of Alzheimer-amyloidosis.
    Melnikova T; Fromholt S; Kim H; Lee D; Xu G; Price A; Moore BD; Golde TE; Felsenstein KM; Savonenko A; Borchelt DR
    J Neurosci; 2013 Feb; 33(9):3765-79. PubMed ID: 23447589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neprilysin overexpression inhibits plaque formation but fails to reduce pathogenic Abeta oligomers and associated cognitive deficits in human amyloid precursor protein transgenic mice.
    Meilandt WJ; Cisse M; Ho K; Wu T; Esposito LA; Scearce-Levie K; Cheng IH; Yu GQ; Mucke L
    J Neurosci; 2009 Feb; 29(7):1977-86. PubMed ID: 19228952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model.
    Herline K; Prelli F; Mehta P; MacMurray C; Goñi F; Wisniewski T
    Alzheimers Res Ther; 2018 Jun; 10(1):54. PubMed ID: 29914551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RAPGEF2 mediates oligomeric Aβ-induced synaptic loss and cognitive dysfunction in the 3xTg-AD mouse model of Alzheimer's disease.
    Jang YN; Jang H; Kim GH; Noh JE; Chang KA; Lee KJ
    Neuropathol Appl Neurobiol; 2021 Aug; 47(5):625-639. PubMed ID: 33345400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain oligomeric β-amyloid but not total amyloid plaque burden correlates with neuronal loss and astrocyte inflammatory response in amyloid precursor protein/tau transgenic mice.
    DaRocha-Souto B; Scotton TC; Coma M; Serrano-Pozo A; Hashimoto T; Serenó L; Rodríguez M; Sánchez B; Hyman BT; Gómez-Isla T
    J Neuropathol Exp Neurol; 2011 May; 70(5):360-76. PubMed ID: 21487307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid-β plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer's disease.
    Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM
    BMC Neurosci; 2019 Mar; 20(1):13. PubMed ID: 30894120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulforaphane Inhibits the Generation of Amyloid-β Oligomer and Promotes Spatial Learning and Memory in Alzheimer's Disease (PS1V97L) Transgenic Mice.
    Hou TT; Yang HY; Wang W; Wu QQ; Tian YR; Jia JP
    J Alzheimers Dis; 2018; 62(4):1803-1813. PubMed ID: 29614663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
    Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuronal Protein Tyrosine Phosphatase 1B Hastens Amyloid β-Associated Alzheimer's Disease in Mice.
    Ricke KM; Cruz SA; Qin Z; Farrokhi K; Sharmin F; Zhang L; Zasloff MA; Stewart AFR; Chen HH
    J Neurosci; 2020 Feb; 40(7):1581-1593. PubMed ID: 31915254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High order W02-reactive stable oligomers of amyloid-β are produced in vivo and in vitro via dialysis and filtration of synthetic amyloid-β monomer.
    Robb E; Perez K; Hung LW; Masters CL; Barnham KJ; Cherny RA; Bush AI; Adlard PA; Finkelstein DI
    J Alzheimers Dis; 2015; 44(1):69-78. PubMed ID: 25182735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease.
    Kawarabayashi T; Younkin LH; Saido TC; Shoji M; Ashe KH; Younkin SG
    J Neurosci; 2001 Jan; 21(2):372-81. PubMed ID: 11160418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in the brain and plasma Aβ peptide levels with age and its relationship with cognitive impairment in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Izco M; Martínez P; Corrales A; Fandos N; García S; Insua D; Montañes M; Pérez-Grijalba V; Rueda N; Vidal V; Martínez-Cué C; Pesini P; Sarasa M
    Neuroscience; 2014 Mar; 263():269-79. PubMed ID: 24447596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-β-sheet conformation monoclonal antibody reduces tau and Aβ oligomer pathology in an Alzheimer's disease model.
    Goñi F; Martá-Ariza M; Herline K; Peyser D; Boutajangout A; Mehta P; Drummond E; Prelli F; Wisniewski T
    Alzheimers Res Ther; 2018 Jan; 10(1):10. PubMed ID: 29378642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an Alzheimer's disease model mouse.
    Chung E; Ji Y; Sun Y; Kascsak RJ; Kascsak RB; Mehta PD; Strittmatter SM; Wisniewski T
    BMC Neurosci; 2010 Oct; 11():130. PubMed ID: 20946660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline.
    Koss DJ; Jones G; Cranston A; Gardner H; Kanaan NM; Platt B
    Acta Neuropathol; 2016 Dec; 132(6):875-895. PubMed ID: 27770234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental traumatic brain injury induces rapid aggregation and oligomerization of amyloid-beta in an Alzheimer's disease mouse model.
    Washington PM; Morffy N; Parsadanian M; Zapple DN; Burns MP
    J Neurotrauma; 2014 Jan; 31(1):125-34. PubMed ID: 24050316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral Immunization with Soybean Storage Protein Containing Amyloid-β 4-10 Prevents Spatial Learning Decline.
    Kawarabayashi T; Terakawa T; Takahashi A; Hasegawa H; Narita S; Sato K; Nakamura T; Seino Y; Hirohata M; Baba N; Ueda T; Harigaya Y; Kametani F; Maruyama N; Ishimoto M; St George-Hyslop P; Shoji M
    J Alzheimers Dis; 2019; 70(2):487-503. PubMed ID: 31177217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct pools of beta-amyloid in Alzheimer disease-affected brain: a clinicopathologic study.
    Steinerman JR; Irizarry M; Scarmeas N; Raju S; Brandt J; Albert M; Blacker D; Hyman B; Stern Y
    Arch Neurol; 2008 Jul; 65(7):906-12. PubMed ID: 18625856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Aβ antibodies incapable of reducing cerebral Aβ oligomers fail to attenuate spatial reference memory deficits in J20 mice.
    Mably AJ; Liu W; Mc Donald JM; Dodart JC; Bard F; Lemere CA; O'Nuallain B; Walsh DM
    Neurobiol Dis; 2015 Oct; 82():372-384. PubMed ID: 26215784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.